Kitajima Sanso has held an opening ceremony for the local subsidiary Kitajima and a medical oxygen filling plant on the site of Kitajima in Yangon City, reports The Gas Review.

Kitajima Sanso created the local subsidiary and opened the oxygen filling plant to create an environment where the same medical care as received in Japan could be received in Myanmar.

At the opening ceremony, President of Kitajima Sano Hiroko Shinohara said, “Since we opened our brand office in 2015, we have been blessed with the understanding and cooperation of many people, allowing us to arrive this great day.”

Managing Director, Bradley Shelley of Kitajima commented, “The opening of this new filling plant will bring further growth to medicine in Myanmar as well as to Kitajima Sanso. Of course, we will not achieve this alone. I’d like to ask all of you for your continued support.”

Six years in Myanmar

Following the opening, a dinner was held for participants of the ceremonies. At the dinner Shinohara said, “In 1952 not long after the end of the war, our founder started a gas business in Tokushima.”

“Who would have known that our experiences and track record since that time would lead us to Myanmar. In the beginning, the company started with industrial and household gases, but around 50 years ago we started medical gas business.”

“Now, people see us as a company that can safely and reliably provide service 24 hours a day, 365 days a year. Our system that provides high-quality medical gases is second to none, and we will continue our never-ending efforts to continue our business.”

The basis of the business is the Kitajima ROB (responsible oxygen cycle) system. The system integrates the management of medical gases from production through patient to achieve safe, quality and stable supply.

The filling plant has two storage tanks, 10 and 20 tonnes, and has filling facilities for 80 cylinders in cleanroom (20 x 4 rows), reports The Gas Review.

The company will train everyone from the filling plant, workers and distributors to medical institute staff to achieve the same system as found in Japan.

“We are linking all areas related to Japanese medical gases, including manufacturing, sales, distribution, general affairs, and management, to involve the entire company in the project,” said Shinohara.

“The unity of existing staff members is increasing, and the consciousness of local staff is gradually changing as a synergistic effect.”

Looking to the future, Shinohara commented, “We will work with affiliated companies to increase the medical level of Myanmar and help as many people as possible.”